Sangamo Therapeutics Inc (NASDAQ:SGMO)
| 8.53 Delayed Data As of Feb 28 |  +1.86 / +27.98%Today’s Change | 6.43 Today|||52-Week Range 13.91 | +1.91% Year-to-Date |
Latest SGMO News | Press Releases
| Here's Why Sangamo Therapeutics Jumped Higher Today Feb 28 / MotleyFool.com - Paid Partner Content | Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39% Feb 27 / MotleyFool.com - Paid Partner Content |
| Sangamo Therapeutics Inc (SGMO) Q4 2019 Earnings Call Transcript Feb 28 / MotleyFool.com - Paid Partner Content | BioMarin's Novel Treatment Promises to Disrupt Competitors Feb 26 / MotleyFool.com - Paid Partner Content |
| Can CRISPR Therapeutics Double Your Money in 2020? Feb 28 / MotleyFool.com - Paid Partner Content | Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease Feb 23 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 6.67 |
| Today’s open | 8.93 |
| Day’s range | 8.02 - 9.19 |
| Volume | 10,057,101 |
| Average volume (3 months) | 1,607,696 |
| Market cap | $863.7M |
Data as of 02/28/2020
Growth & Valuation
| Earnings growth (last year) | -0.70% |
| Earnings growth (this year) | -75.36% |
| Earnings growth (next 5 years) | -17.98% |
| Revenue growth (last year) | +130.95% |
| P/E ratio | -- |
| Price/Sales | 13.18 |
| Price/Book | 2.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IMGNImmunoGen Inc | +0.06 | +1.37% |
| RYTMRhythm Pharmaceutica... | +0.92 | +5.10% |
| STOKStoke Therapeutics I... | +1.96 | +8.60% |
| CARACara Therapeutics In... | -0.32 | -2.08% |
Data as of 02/28/2020
Financials
| Next reporting date | May 12, 2020 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $84.5M |
| Annual profit (last year) | -$68.3M |
| Net profit margin | -80.91% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Richmond, California |
Forecasts
